AFFF Firefighting Foam Lawsuit
(PFAS "Forever Chemicals")
This environmental contamination litigation involves PFAS chemicals from firefighting foam that have contaminated drinking water supplies across America. Tens of thousands of plaintiffs, including firefighters, military personnel, and people in communities near contaminated sites, are seeking compensation for cancer and other serious health conditions. On November 3, 2026, 3M agreed to pay up to $7.35 billion to resolve personal-injury claims against it. Claims against the other defendants continue.
Key Takeaways
- 3M agreed to pay up to $7.35 billion (about $5.8 billion in present value) on November 3, 2026 to resolve personal-injury claims of about 115,000 to 120,000 plaintiffs. The deal is opt-in and depends on sealed participation thresholds
- November 13, 2026 is the deadline to identify eligible claimants to the court. Six injuries qualify: kidney, testicular, liver, and thyroid cancer, ulcerative colitis, and thyroid disease
- Over 15,270 cases pending as of November 2026 with 100% growth
- More than $11 billion in water-provider settlements reached with major manufacturers
- PFAS chemicals classified as carcinogenic (Group 1) by IARC in November 2023
- Firefighters, military personnel, and contaminated communities are primary plaintiffs
- EPA set drinking water limit at 4 parts per trillion in 2024
November 2026 Updates Latest
On November 3, 2026, 3M signed an opt-in settlement to pay up to $7.35 billion over nine years (about $5.8 billion in present value) for the personal-injury claims of about 115,000 to 120,000 plaintiffs with one of six injuries. On November 4, Judge Gergel entered CMO 39, which requires every eligible claimant to be identified by November 13, 2026, and CMO 40, which stays personal-injury proceedings against 3M and sets strict record and expert-report deadlines for anyone who declines. The deal depends on sealed participation thresholds, and either side can walk away if they are not met. Claims against DuPont, Chemours, Corteva, and the other defendants are not settled. 15,270 cases are pending (19,846 total), up 6 from the October report. Full settlement breakdown below.
3M signs an up-to-$7.35 billion personal-injury settlement; the court enters CMO 39 and CMO 40 (Nov 3 and 4)
On November 3, 2026, 3M and the plaintiffs' Negotiating Plaintiffs' Counsel signed a Master Settlement Agreement, which 3M filed with the SEC that evening. It covers six injuries (kidney, testicular, liver, and thyroid cancer, ulcerative colitis, and thyroid disease) and exposure through drinking water or direct exposure. Every amount in the payment schedule is a maximum: $6.27 billion in six installments from 2028 to 2033, a $50 million initial payment, and up to $1.03 billion in reserve, threshold, and bonus payments. 3M can walk away if sealed participation thresholds are not met. On November 4, the court entered CMO 39 (identification deadline November 13) and CMO 40, which stays personal-injury proceedings against 3M and requires anyone who declines to produce records within 60 days and expert reports within 120 days, or face dismissal with prejudice. Read the full breakdown. See what CMO 39 and CMO 40 require.
3M's October 20 quarterly report: claims vetting "substantially complete," mediation continues, no trial date
In its Form 10-Q filed October 20, 2026, 3M said the special master appointed in June 2026 issued a report in September on defendants' first two sets of motions to dismiss plaintiffs who had not met the court's information requirements, recommending that most of the targeted claims be dismissed. According to 3M, the court largely adopted that report, and the vetting process is "now substantially complete, with tens of thousands of claims being dismissed without prejudice." 3M also said defendants' August 2026 motions to exclude expert testimony on liver and thyroid cancer remain pending, no new personal-injury trial date has been set, and court-ordered settlement talks on the personal-injury claims are "being actively facilitated by a court-appointed mediator." Two weeks later, those talks produced the November 3 settlement.
DuPont, Chemours and Corteva settle North Carolina's PFAS claims for $455 million (Sep 10, 2026)
On September 10, 2026, DuPont, Chemours and Corteva settled with North Carolina and 11 local entities for $455 million over 15 years (present value about $355 million). The deal resolves claims over the Fayetteville Works plant and the State's other PFAS claims, including from the use of AFFF. Of the total, $18 million is for non-Fayetteville claims, and no more than $14.4 million is for AFFF. It is not a personal-injury settlement.
The Group B bellwether schedule and the other defendants
CMO 38 (June 3, 2026) requires one action per personal-injury plaintiff. Under CMO 26O (July 30, 2026), proposals for selecting the Group B personal-injury bellwether cases (thyroid disease and ulcerative colitis) and for expert discovery are due November 20, 2026. Under CMO 33F (August 31, 2026), responses to Rule 702 expert motions on thyroid and liver cancer are due November 20, 2026, with replies due January 22, 2027. The new CMO 40 stay applies only to claims against 3M, and we had found no order changing the November 20 deadlines as of November 4. No other defendant has settled personal-injury claims. DuPont reported about 13,700 personal-injury cases in the MDL as of September 30, 2026 and said it continues talks with a mediator. More than $11 billion in water-provider settlements (including the DuPont/Chemours $1.185B public water suppliers fund) remain finally approved.
Key Facts (November 2026)
| Pending Actions | 15,270+ cases in federal MDL |
| 3M Personal-Injury Settlement | Up to $7.35 billion, 2026 to 2034 (present value about $5.8 billion); signed November 3, 2026 |
| Eligible Injuries (3M deal) | Kidney, testicular, liver, and thyroid cancer; ulcerative colitis; thyroid disease |
| Claimant ID Deadline | November 13, 2026 (CMO 39) |
| Water-Provider Settlements | More than $11 billion (3M, DuPont/Chemours) |
| 3M Water-Supplier Settlement | $10.3 billion over 13 years (2023) |
| IARC Classification | Group 1: Carcinogenic to humans (PFOA) |
| EPA Drinking Water Limit | 4 parts per trillion (PFOA/PFOS) |
| Presiding Judge | Hon. Richard M. Gergel (D.S.C.) |
| MDL Created | December 2018 |
| Personal Injury Claims vs 3M | Opt-in settlement; non-participants and new filers proceed under CMO 40 |
| Personal Injury Claims vs Others | Not settled; DuPont reports about 13,700 PI cases in the MDL |
The 3M Personal-Injury Settlement
3M has agreed to pay up to $7.35 billion over nine years to resolve PFAS personal-injury claims in this MDL. The agreement, signed with the plaintiffs' Negotiating Plaintiffs' Counsel and filed with the SEC on November 3, 2026, is an opt-in settlement, not a class action: each eligible claimant decides whether to join. It is the first broad personal-injury resolution in MDL-2873. 3M admits no liability. Claims against DuPont, Chemours, Corteva, and the other defendants are not part of it.
Who is eligible
A person with a PFAS personal-injury claim asserting one of six "Eligible Injuries," whether or not the claim has been filed, served, or tolled, and in this MDL or another court.
- •Exposure: through drinking water, from a public water system or a private well, or through direct exposure, such as handling AFFF.
- •Not eligible: other health conditions, and property or business damage claims brought without a qualifying injury.
- •Awards: scored on the diagnosis and the claimant's PFAS exposure. The scoring rules have not been made public, so there is no verified per-person amount.
How it works, step by step
- Nov 3, 2026Agreement signed
3M and the plaintiffs’ Negotiating Plaintiffs’ Counsel sign the Master Settlement Agreement, filed with 3M’s Form 8-K.
- Nov 13, 2026Identification deadline (CMO 39)
Lawyers must identify every eligible client, filed or not. People without a lawyer can identify themselves only if they already have a case in the MDL. Being identified does not commit anyone to join.
- 10 to 14 days laterFile and complete a fact sheet
Identified claimants without a pending case must be filed in the MDL within 10 days, and anyone without a fact sheet must submit one within 14 days. Fact sheets submitted after November 3 bind claimants to the injuries and exposure they list.
- Final listThe claimant list closes
Lawyers cannot add clients who hired them after November 13. Anyone not on the final list can join only if both sides consent.
- EstimatesEstimated award tables
Each claimant gets an estimate that assumes only the main payment and 100% participation. It is not a guarantee.
- 98 days laterRegistration deadline
Each claimant chooses: join, decline and stop litigating, or decline and keep litigating. The choice is binding and irrevocable.
- Participation countWalk-away window
3M has 45 days after it receives the participation numbers to decide whether to terminate. Plaintiffs’ negotiating counsel has its own termination right.
- Jan 15, 2028+First main installment
$1.045 billion, then five more through July 2033. Reserve payments run to April 2034.
Payment schedule (maximums)
From Exhibit 11 to the settlement agreement. All payments after the first $50 million depend on neither side exercising its termination rights. Total: $7.35B.
The participation test
The deal measures an overall participation rate and a separate rate for kidney and testicular cancer claimants with higher exposure. The required percentages are sealed. 3M has 45 days after it gets the numbers to decide whether to walk away, and plaintiffs' negotiating counsel has its own termination right. Joining is binding and irrevocable, and participants waive punitive damages.
If you don't join (CMO 40)
Claimants who decline, and anyone who files a new PFAS injury case against 3M in the MDL, must produce records and a sworn statute of limitations declaration within 60 days, including pharmacy records reaching back 10 years before diagnosis and proof they were at a home or other site served by contaminated water before diagnosis (private-well users need PFAS test results for the well). Within 120 days they must serve case-specific expert reports, including a fate and transport report tracing the PFAS into their water for drinking-water claims. Form expert reports are banned. Missing a deadline after a 30-day cure period means dismissal with prejudice. The order lasts at least 9 years. Full CMO 40 requirements.
What it does not cover
Personal-injury claims against DuPont, Chemours, Corteva, and other defendants; the new stay applies only to 3M. Water-provider claims, which were settled separately in 2023. Purchaser claims over firefighter turnout gear in MDL-3191. Conditions other than the six eligible injuries.
Still not public
- • The participation percentages (Confidential Exhibit 12, sealing requested)
- • The points matrix and the dollar value of a point
- • Which companies are excluded from the release (Exhibit 9)
- • Whether turnout-gear exposure scores as direct exposure
- • Exact registration dates, which run from when estimates issue
- • Whether the November 20 bellwether and expert deadlines change for other defendants
Sources: 3M Form 8-K and Master Settlement Agreement with Exhibit 11 (Nov. 3, 2026); 3M press release (Nov. 3, 2026) and investor presentation (Nov. 4, 2026); CMO 39 and CMO 40, MDL No. 2:18-mn-2873-RMG (D.S.C. Nov. 4, 2026); DuPont Form 10-Q (Nov. 3, 2026).
November 2023: PFOA Classified as "Carcinogenic to Humans"
The World Health Organization's International Agency for Research on Cancer (IARC) upgraded PFOA to Group 1 (carcinogenic to humans)—the highest classification—based on sufficient evidence for cancer in experimental animals and strong mechanistic evidence in humans. This is the same classification as asbestos and tobacco.
Source: IARC Monographs Volume 135, December 2023
Explosive Case Growth
One of the fastest-growing environmental MDLs. Case count has more than doubled in 2025, surging 100% as water contamination claims continue to be filed nationwide.
Source: JPML MDL Statistics Reports, January 2025-November 2026
1 Understanding PFAS: The "Forever Chemicals"
PFAS (per- and polyfluoroalkyl substances) are a group of manufactured chemicals that have been used since the 1940s. They're called "forever chemicals" because the carbon-fluorine bonds that make them so effective also make them nearly indestructible—they don't break down in the environment and can accumulate in your body over time.
AFFF (Aqueous Film-Forming Foam) is a firefighting foam specifically designed to extinguish fuel-based fires. According to the EPA, AFFFs containing PFAS have been used at airports, shipyards, military bases, firefighting training facilities, chemical plants, and refineries for decades.
Key PFAS Compounds in AFFF
Source: CDC/ATSDR ToxFAQs for Perfluoroalkyls
2 Proven Health Effects of PFAS Exposure
Multiple government health agencies have confirmed that PFAS exposure causes serious health problems. Here's what the science shows:
Cancer Links (IARC/EPA/NCI Confirmed)
Sources: IARC Monographs Vol. 135; NCI Cancer Trends Progress Report; EPA PFAS Health Understanding
From EPA Studies
- Decreased fertility in women
- High blood pressure in pregnant women
- Developmental delays in children
- Hormone interference
- Increased cholesterol/obesity risk
From CDC/ATSDR (July 2025)
- Changes in liver enzymes
- Lower antibody response to vaccines
- Pregnancy-induced hypertension
- Preeclampsia
- Small decreases in birth weight
Immune System Damage (NTP Finding)
In 2016, the National Toxicology Program concluded that both PFOA and PFOS are "presumed to be an immune hazard to humans" based on high-level evidence from animal studies showing suppressed antibody response and moderate evidence from human studies.
Source: NTP Monograph on Immunotoxicity, September 2016
3 Who Has Been Exposed to PFAS?
Firefighters
IARC's 2023 evaluation of firefighting lists chemicals in firefighting foams, such as PFAS, among the exposures firefighters face, and classifies occupational exposure as a firefighter as carcinogenic to humans (Group 1). IARC also notes that people exposed to PFOA and PFOS at work can have high levels of exposure, mainly through inhalation.
- • Airport firefighters
- • Military firefighters
- • Municipal firefighters
- • Industrial firefighters
Military Personnel
AFFF was extensively used at military bases for fire training and aircraft emergencies. The CDC/ATSDR is currently conducting exposure assessments at communities near military installations.
- • Air Force base personnel
- • Naval base workers
- • Army base firefighters
- • Coast Guard personnel
Communities Near Contaminated Sites
PFAS have contaminated groundwater and drinking water supplies near locations where AFFF was used. The main exposure pathway for the general public is drinking contaminated water.
- • Near military bases
- • Near airports
- • Near refineries
- • Near training facilities
Industrial Workers
Workers at PFAS manufacturing facilities, those using PFAS in production, and waste management workers handling PFAS-contaminated materials face occupational exposure.
4 The Litigation: MDL-2873
The Judicial Panel on Multidistrict Litigation consolidated AFFF cases in South Carolina because they share common questions about whether PFAS-containing firefighting foams contaminated groundwater and caused harm to people and communities.
5 Major Settlements
On November 3, 2026, 3M signed an opt-in settlement to pay up to $7.35 billion from 2026 through 2034 (present value about $5.8 billion) for the personal-injury claims of about 115,000 to 120,000 plaintiffs with kidney, testicular, liver, or thyroid cancer, ulcerative colitis, or thyroid disease. It depends on sealed participation thresholds. See the breakdown above.
3M agreed to pay $10.3 billion over 13 years to settle claims from public water systems. This is one of the largest environmental settlements in U.S. history and will help fund water treatment and remediation efforts.
DuPont, Chemours, and Corteva agreed to pay $1.185 billion to settle water contamination claims from municipalities and water districts.
On September 10, 2026, DuPont, Chemours, and Corteva settled with North Carolina and 11 local entities for $455 million over 15 years (present value about $355 million). The deal resolves claims over the Fayetteville Works plant and the State's other PFAS claims, including from AFFF use. Only $18 million is for non-Fayetteville claims, and no more than $14.4 million is for AFFF. It is not a personal-injury settlement.
Important: The 2023 settlements resolved claims from water utilities, not individuals. Personal-injury claims against 3M are now addressed by the November 2026 opt-in settlement. Personal-injury claims against DuPont, Chemours, Corteva, and the other defendants have not been settled and continue.
6 EPA Drinking Water Standards (April 2024)
In April 2024, the EPA finalized the first-ever national drinking water standards for PFAS. These regulations set strict limits and require action by water systems. In May 2026, the EPA proposed changes to these standards (see below). The proposal is not final.
Maximum Contaminant Levels (MCLs)
| Compound | Goal (MCLG) | Enforceable Limit |
|---|---|---|
| PFOA | Zero | 4.0 parts per trillion |
| PFOS | Zero | 4.0 parts per trillion |
| PFHxS | 10 ppt | 10 parts per trillion (proposed for rescission) |
| PFNA | 10 ppt | 10 parts per trillion (proposed for rescission) |
| GenX (HFPO-DA) | 10 ppt | 10 parts per trillion (proposed for rescission) |
Source: EPA Safe Drinking Water Act PFAS Regulations, April 2024
May 2026 proposal (not final): On May 18, 2026, the EPA proposed keeping the 4.0 ppt limits for PFOA and PFOS, with an optional two extra years (to 2031) to comply, and rescinding the limits for PFHxS, PFNA, GenX, and the hazard index. These changes are proposed, not final.
Public water systems must complete initial PFAS monitoring
Treatment solutions must be implemented if levels exceed MCLs. The May 2026 proposal would allow an optional two extra years, to 2031, for PFOA and PFOS.
7 Do You Qualify for Compensation?
You may be eligible if you have documented PFAS exposure AND have been diagnosed with a qualifying condition. Timing now matters: under the 3M settlement, every eligible claimant must be identified to the court by November 13, 2026, and lawyers cannot add clients who hire them after that date.
Exposure Evidence Needed
- Used AFFF as a firefighter or military personnel
- Lived or worked near a military base, airport, or industrial facility using AFFF
- Drank water from a contaminated municipal supply or private well
- Blood tests showing elevated PFAS levels
Eligible Injuries Under the 3M Settlement
These are the only six "Eligible Injuries" in the agreement. Other conditions associated with PFAS in health studies, such as high cholesterol or pregnancy-related conditions, are not eligible injuries under the 3M deal.
Medical Testing: In July 2022, the National Academies of Sciences recommended that doctors offer PFAS blood testing to patients with likely elevated exposure history. Ask your doctor about testing if you believe you've been exposed.
8 Frequently Asked Questions
Is there a 3M AFFF personal injury settlement?
What happens if I don't join the 3M settlement?
How do I know if my water is contaminated with PFAS?
Do I need a cancer diagnosis to file a claim?
I'm a firefighter. Am I eligible?
What does the IARC Group 1 classification mean?
Did the $10.3 billion settlement resolve all claims?
Can I get a blood test for PFAS?
Sources & References
16 official sources cited• EPA: "Our Current Understanding of the Human Health and Environmental Risks of PFAS"
• CDC/ATSDR: "PFAS and Your Health" (Updated July 2025)
• IARC Monographs Volume 135 (December 2023)
• IARC Monographs Volume 132: Occupational Exposure as a Firefighter (2023)
• National Cancer Institute: Cancer Trends Progress Report
• National Toxicology Program: Monograph on Immunotoxicity (2016)
• EPA Safe Drinking Water Act PFAS Regulations (April 2024)
• EPA: Proposed changes to the PFAS drinking water regulation (May 18, 2026)
• U.S. District Court (D.S.C.), MDL-2873 case management orders: CMO 38 (June 3, 2026), CMO 26O (July 30, 2026), CMO 33F (August 31, 2026)
• 3M Company: Form 10-Q for the quarter ended September 30, 2026 (filed October 20, 2026)
• 3M Company: Form 8-K and Master Settlement Agreement with Exhibit 11 (Payment Schedule), filed November 3, 2026
• 3M Company: "3M Reaches Broad Resolution of AFFF Personal Injury Litigation," press release (November 3, 2026), and investor presentation (November 4, 2026)
• U.S. District Court (D.S.C.), MDL-2873: CMO 39 (Identification Order) and CMO 40, entered November 4, 2026
• U.S. District Court (D.S.C.), MDL-2873: joint motion to file Confidential Exhibit 12 under seal (November 3, 2026)
• DuPont de Nemours: Form 10-Q for the quarter ended September 30, 2026 (filed November 3, 2026)
• DuPont: North Carolina settlement release, filed with the SEC (September 2026)
Attorney Advertising. The information on this page is provided for general informational purposes only and does not constitute legal advice. No attorney-client relationship is created by accessing or using this content.
Every case is unique, and results depend on the specific facts and circumstances involved. Past settlement amounts and case outcomes do not guarantee similar results in your case. If you believe you have a legal claim, you should consult with a licensed attorney in your jurisdiction who can evaluate your specific situation.